IMPAIRED ADIPOGENESIS IN INSULIN RESISTANCE

胰岛素抵抗中脂肪生成受损

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Obesity is a strong risk factor for developing type 2 diabetes (T2DM), but the reasons for this are not fully understood. In particular, it is not known why some obese people develop T2DM while other obese individuals do not. This study tests whether differences in fat cells (adipocytes) are to blame. Even in adults, fat cells are constantly being formed to replace old fat cells and to respond to the body's need to store excess energy. The ability to form new fat cells may be diminished in some individuals, leading to larger fat cells. These large fat cells secrete hormones that may increase risk for T2DM. This study tests whether fat cells from obese insulin resistant subjects (who are at risk for developing T2DM) form at a slower rate than those from insulin sensitive subjects (who are at lower risk for developing T2DM). To address this question we will recruit and study two groups of obese subjects, selected to be similar in age, gender and degree of obesity. One group of subjects will be obese and insulin resistant (the OIR group), while the other will be comparably obese, but insulin sensitive (OIS). Subjects will undergo a series of studies to characterize their metabolism including measurement of body fat by DXA scanning, oral glucose tolerance (a test used to diagnose diabetes) and measurement of insulin sensitivity in response to an infusion of insulin (a research study used to classify patients into the OIR and OIS groups). Small samples of fat (from just under the skin of the belly and the buttocks) will obtained using a needle on two occasions over 12 weeks. During these 12 weeks, subjects will drink a small amount of water that contains a non-radioactive label. This labeled water will allow us to measure the rate of growth of new fat cells in the body. We will also look at the rate of growth of fat cells obtained from these biopsies in the laboratory. The results of this study may tell us more about why certain obese people develop diabetes and why others do not. This might lead to new ways to prevent or treat T2DM.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 肥胖是发展2型糖尿病(T2 DM)的一个强有力的危险因素,但其原因尚不完全清楚。特别是,目前尚不清楚为什么一些肥胖的人发展T2 DM,而其他肥胖的人没有。这项研究测试了脂肪细胞(脂肪细胞)的差异是否是罪魁祸首。即使在成年人中,脂肪细胞也在不断形成,以取代旧的脂肪细胞,并响应身体储存多余能量的需要。在某些个体中,形成新脂肪细胞的能力可能会减弱,导致更大的脂肪细胞。这些大的脂肪细胞分泌的激素可能会增加T2 DM的风险。本研究测试了肥胖胰岛素抵抗受试者(有发生T2 DM的风险)的脂肪细胞形成速度是否慢于胰岛素敏感受试者(发生T2 DM的风险较低)。 为了解决这个问题,我们将招募和研究两组肥胖受试者,选择在年龄,性别和肥胖程度相似。一组受试者肥胖且胰岛素抵抗(OIR组),而另一组受试者相对肥胖,但胰岛素敏感(OIS)。受试者将接受一系列研究以表征其代谢,包括通过DXA扫描测量体脂、口服葡萄糖耐量(用于诊断糖尿病的测试)和测量胰岛素输注后的胰岛素敏感性(用于将患者分为OIR和OIS组的研究)。在12周内,将使用针头在两个场合获得少量脂肪样本(来自腹部和臀部皮肤下)。在这12周内,受试者将饮用少量含有非放射性标记的水。这种标记的水将使我们能够测量体内新脂肪细胞的生长速度。我们还将在实验室中观察从这些活检中获得的脂肪细胞的生长速度。 这项研究的结果可能会告诉我们更多关于为什么某些肥胖的人患糖尿病,为什么其他人没有。 这可能会导致预防或治疗T2 DM的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD E PRATLEY其他文献

RICHARD E PRATLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD E PRATLEY', 18)}}的其他基金

NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE I DIABETES
I 型糖尿病发展的自然史研究
  • 批准号:
    8166968
  • 财政年份:
    2010
  • 资助金额:
    $ 2.42万
  • 项目类别:
CLINICAL TRIAL: EFFECTS OF PIOGLITAZONE ON INCRETIN AXIS IN PTS W TYPE 2 DIABETE
临床试验:吡格列酮对 2 型糖尿病 PTS 肠促胰岛素轴的影响
  • 批准号:
    8166982
  • 财政年份:
    2010
  • 资助金额:
    $ 2.42万
  • 项目类别:
IMPAIRED ADIPOGENESIS IN INSULIN RESISTANCE: PILOT CLINICAL AMP IN VITRO STUDIES
胰岛素抵抗中脂肪生成受损:体外试验临床 AMP 研究
  • 批准号:
    8166981
  • 财政年份:
    2010
  • 资助金额:
    $ 2.42万
  • 项目类别:
CLINICAL TRIAL: EFFECTS OF SITAGLIPTIN ON BONE TURNOVER IN PTS WITH TYPE 2 DIABE
临床试验:西他列汀对 2 型糖尿病患者骨转换的影响
  • 批准号:
    8166983
  • 财政年份:
    2010
  • 资助金额:
    $ 2.42万
  • 项目类别:
CLINICAL TRIAL: EFFECTS OF PIOGLITAZONE ON INCRETIN AXIS IN PTS W TYPE 2 DIABETE
临床试验:吡格列酮对 2 型糖尿病 PTS 肠促胰岛素轴的影响
  • 批准号:
    7952123
  • 财政年份:
    2009
  • 资助金额:
    $ 2.42万
  • 项目类别:
WEIGHT LOSS & ASTHMA
减肥
  • 批准号:
    7959624
  • 财政年份:
    2009
  • 资助金额:
    $ 2.42万
  • 项目类别:
NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE I DIABETES
I 型糖尿病发展的自然史研究
  • 批准号:
    7952105
  • 财政年份:
    2009
  • 资助金额:
    $ 2.42万
  • 项目类别:
Impaired adipogenesis in insulin resistance: pilot clinical and in-vitro studies
胰岛素抵抗中脂肪生成受损:试点临床和体外研究
  • 批准号:
    8001118
  • 财政年份:
    2009
  • 资助金额:
    $ 2.42万
  • 项目类别:
NON-INVASIVE GLUCOSE MONITORING USING EXHALED BREATH CONDENSATE
使用呼出气体冷凝液进行无创血糖监测
  • 批准号:
    7952116
  • 财政年份:
    2009
  • 资助金额:
    $ 2.42万
  • 项目类别:
CLINICAL TRIAL: EFFECTS OF SITAGLIPTIN ON BONE TURNOVER IN PTS WITH TYPE 2 DIABE
临床试验:西他列汀对 2 型糖尿病患者骨转换的影响
  • 批准号:
    7952124
  • 财政年份:
    2009
  • 资助金额:
    $ 2.42万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 2.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterizing breast cancer invasion and proliferation when co-aggregated with adipocytes in multicellular spheroids created with a custom bioreactor to augment cell-cell connectivity.
当与多细胞球体中的脂肪细胞共聚集时,表征乳腺癌的侵袭和增殖,该多细胞球体是用定制生物反应器创建的,以增强细胞间的连接。
  • 批准号:
    10334113
  • 财政年份:
    2022
  • 资助金额:
    $ 2.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了